세계의 특정 IgG4 검사 시장 보고서(2025년)
Specific Immunoglobulin G Subclass 4 (IgG4) Testing Global Market Report 2025
상품코드 : 1889584
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,559,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,481,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,403,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

특정 IgG4 검사 시장 규모는 최근 급속히 확대되고 있습니다. 2024년 12억 2,000만 달러로 평가되었고, 2025년에는 13억 7,000만 달러에 달할 것으로 추정되며, CAGR 12.6%로 성장이 전망되고 있습니다. 지난 수년간의 성장은 식이 과민증의 유병률 증가, 면역 관련 질환에 대한 인식 향상, 진보된 진단 서비스에 대한 수요 증가, 헬스케어 지출 급증, 전문 실험실 확대, 개인화된 식단 관리에 대한 관심 증가로 이어졌습니다.

특정 IgG4 검사 시장 규모는 향후 수년간 급속한 성장이 예상됩니다. 2029년에는 21억 7,000만 달러에 달할 것으로 예측되며, CAGR 12.3%로 성장할 전망입니다. 예측 기간의 성장은 만성 염증성 질환의 스크리닝 증가, 예방 헬스케어에 대한 중시 증가, 병원에서의 고급 면역학 검사 도입 확대, 알레르기 관리에 대한 환자 의식 증가, 민간 진단 검사 기관 확대, 종합적인 면역 프로파일링에 대한 주목 증가에 의해 견인될 전망입니다. 예측 기간 주요 동향으로는 다중 면역 측정 플랫폼의 기술적 진보, 고감도 검출법의 진전, 자동 항체 정량 시스템 혁신, 디지털 보고 및 해석 툴의 개발, 바이오마커에 근거한 면역 평가의 연구 개발, 마이크로플루이딕스 기술을 활용한 진단 검사의 혁신 등을 들 수 있습니다.

알레르기 질환의 유병률 상승은 향후 수년간의 특정 IgG4 검사 시장의 성장을 이끌 것으로 예측됩니다. 알레르기 질환은 일반적으로 무해한 물질에 면역계가 비정상적으로 반응하여 생기는 음식 알레르기, 아토피 피부염, 천식, 알레르기성 비염과 같은 면역 매개 과민성 질환입니다. 이러한 유병률의 상승은 식습관의 변화와 관련이 있으며, 고도로 가공된 식품의 섭취 증가는 장내 세균총을 변화시켜 알레르기 감작을 발병할 위험을 높일 수 있습니다. 특정 IgG4 검사는 알레르겐에 대한 반복 노출과 관련된 면역 반응을 평가하는 데 도움이 되며, 임상의는 내용 패턴을 이해하고 복잡한 알레르기 관련 면역 활동을 해석하는 데 도움이 됩니다. 예를 들어 2024년 5월에는 영국 식품안전 및 공중 위생을 담당하는 정부기관인 식품기준청(FSA)이 영국 성인 인구의 약 6%(240만 명)가 임상적으로 확인된 음식 알레르기를 가지고 있다고 보고했습니다. 그 결과, 알레르기 질환의 유병률 증가가 IgG4 검사 시장의 확대를 촉진하고 있습니다.

IgG4 검사 시장의 주요 기업은 검사 플랫폼 및 조사 방법의 혁신에 주력하고 있으며, 고감도 면역 측정 기술 등에 의해 분석 정밀도, 분석 성능, 진단 신뢰성의 향상을 도모하고 있습니다. 고감도 면역 측정법은 최적화된 항체, 강화된 신호 생성 화학, 정교한 분석 워크플로우를 채택한 첨단 검출 시스템으로, 매우 낮은 농도의 분석 대상 물질을 정밀하게 정량합니다. 이 시스템은 감지 한계 개선, 우수한 특이성, 일관된 재현성을 제공합니다. 예를 들어, 2025년 9월에는 미국에 본사를 둔 체외 진단용 면역 측정 솔루션 개발 기업인 Alta DiagnoTech사가 폭넓은 면역학 용도 분야에서 정확한 바이오마커 정량을 실현하는 고감도 면역 측정 제품 라인인 IVD 면역학 검사용 ELISA 키트를 발표했습니다. 이 키트는 분석 민감도 향상, 제조 안정성 강화, 광범위한 적용성을 제공하며, 면역학 검사 워크플로우에서 검사의 신뢰성, 분석 정확성 및 전체 진단의 신뢰성을 향상시킵니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향 및 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁 및 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석 및 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별 및 국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도 및 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹 및 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문 및 전략

제36장 부록

AJY
영문 목차

영문목차

Specific immunoglobulin G subclass 4 (IgG4) testing measures the concentration of IgG4, one of the antibodies produced by the body as part of its immune response. In this test, a blood sample is examined to determine the amount of IgG4 present, as unusually elevated levels may indicate abnormal immune activity. The results help clinicians assess conditions such as IgG4-related disease and gain insight into certain immune or inflammatory responses.

The key product types of specific immunoglobulin G subclass 4 (IgG4) testing include reagents and kits, instruments, and services. Reagents and kits are pre-packaged chemical or biological components designed to support the accurate detection, measurement, or analysis of specific targets in diagnostic testing. The key applications include allergy diagnosis, autoimmune disease diagnosis, research, and others, and these products are used by various end users, such as hospitals and clinics, diagnostic laboratories, research institutes, and additional healthcare settings.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The specific immunoglobulin G subclass 4 (IgG4) testing market research report is one of a series of new reports from The Business Research Company that provides specific immunoglobulin G subclass 4 (IgG4) testing market statistics, including the specific immunoglobulin G subclass 4 (IgG4) testing industry global market size, regional shares, competitors with the specific immunoglobulin G subclass 4 (IgG4) testing market share, detailed specific immunoglobulin G subclass 4 (IgG4) testing market segments, market trends, and opportunities, and any further data you may need to thrive in the specific immunoglobulin G subclass 4 (IgG4) testing industry. This specific immunoglobulin G subclass 4 (IgG4) testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The specific immunoglobulin G subclass 4 (IgG4) testing market size has grown rapidly in recent years. It will grow from $1.22 billion in 2024 to $1.37 billion in 2025 at a compound annual growth rate (CAGR) of 12.6%. The growth in the historic period resulted from the increasing prevalence of food sensitivities, rising awareness of immune-related disorders, growing demand for advanced diagnostic services, a surge in healthcare expenditure, expansion of specialized laboratory testing, and a heightened focus on personalized dietary management.

The specific immunoglobulin G subclass 4 (IgG4) testing market size is expected to see rapid growth in the next few years. It will grow to $2.17 billion in 2029 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period will be driven by increasing screening for chronic inflammatory conditions, rising emphasis on preventive healthcare, growing adoption of advanced immunology testing in hospitals, a surge in patient awareness regarding allergy management, expansion of private diagnostic laboratories, and a growing focus on comprehensive immune profiling. Major trends in the forecast period include technological advancements in multiplex immunoassay platforms, progress in high-sensitivity detection methods, innovations in automated antibody quantification systems, developments in digital reporting and interpretation tools, research and development in biomarker-based immune assessment, and innovations in microfluidics-enabled diagnostic testing.

The rising prevalence of allergic diseases is expected to drive the growth of the specific immunoglobulin G subclass 4 (IgG4) testing market in the coming years. Allergic diseases are immune-mediated hypersensitivity disorders, including food allergies, atopic dermatitis, asthma, and allergic rhinitis, which occur when the immune system reacts abnormally to typically harmless substances. This rise in prevalence is linked to changes in dietary habits, as increased consumption of highly processed foods can alter gut microbiota and increase the risk of developing allergic sensitization. Specific IgG4 testing helps evaluate immune responses associated with repeated allergen exposure, aiding clinicians in understanding tolerance patterns and interpreting complex allergy-related immune activity. For example, in May 2024, the Food Standards Agency (FSA), a UK government body responsible for food safety and public health, reported that approximately 6%, or 2.4 million, of the UK adult population had a clinically confirmed food allergy. As a result, the growing prevalence of allergic diseases is fueling the expansion of the IgG4 testing market.

Leading companies in the IgG4 testing market are focusing on innovations in testing platforms and methodologies, such as high-sensitivity immunoassay technology, to improve assay accuracy, analytical performance, and diagnostic reliability. High-sensitivity immunoassays are advanced detection systems that employ optimized antibodies, enhanced signal-generation chemistries, and refined assay workflows to quantify very low analyte concentrations with precision. These systems offer improved detection limits, superior specificity, and consistent reproducibility. For instance, in September 2025, Alta DiagnoTech, a US-based developer of in vitro diagnostic immunoassay solutions, launched ELISA Kits for IVD Immunology Testing, a high-sensitivity immunoassay product line designed for accurate biomarker quantification across a wide range of immunology applications. The kits offer enhanced assay sensitivity, robust manufacturing stability, and broad applicability, improving test reliability, analytical precision, and overall diagnostic confidence in immunology testing workflows.

In December 2023, Danaher Corporation, a US-based provider of life sciences, diagnostics, and biotechnology solutions, acquired Abcam plc for $5.7 billion. This acquisition allows Danaher to access Abcam's extensive portfolio of antibodies, recombinant proteins, assay kits, and immunoassay reagents, strengthening its specialized immunodiagnostic capabilities, including those supporting IgG4 testing workflows, while expanding its global research infrastructure, operational scale, and customer reach. Abcam plc, a UK-based provider of high-quality biological reagents and research assay solutions, is renowned for its expertise in antibody development and standardized ELISA platforms, including research-grade IgG4-specific tools widely used in immunology and biomarker research.

Major companies operating in the specific immunoglobulin g subclass 4 (igg4) testing market are F Hoffmann La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Mayo Clinic Laboratories, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Eurofins Scientific SE, Revvity, Randox Laboratories Ltd, NeoGenomics Laboratories Inc., ARUP Laboratories, Dr Lal PathLabs Limited, Metropolis Healthcare Ltd, ProSci Incorporated, Leinco Technologies Incorporated, MyBioSource Inc., Boster Biological Technology, PROTIA Inc., Creative Diagnostics LLC.

North America was the largest region in the specific immunoglobulin G subclass 4 (IgG4) testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in specific immunoglobulin G subclass 4 (IgG4) testing report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the specific immunoglobulin G subclass 4 (IgG4) testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The specific immunoglobulin G subclass 4 (IgG4) testing market includes revenues earned by entities by providing services such as sample collection services, specimen transport services, pre-analytical preparation services, data management services, clinical consultation services, and results dissemination services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Specific Immunoglobulin G Subclass 4 (IgG4) Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on specific immunoglobulin g subclass 4 (igg4) testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for specific immunoglobulin g subclass 4 (igg4) testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The specific immunoglobulin g subclass 4 (igg4) testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Specific Immunoglobulin G Subclass 4 (IgG4) Testing Market Characteristics

3. Specific Immunoglobulin G Subclass 4 (IgG4) Testing Market Trends And Strategies

4. Specific Immunoglobulin G Subclass 4 (IgG4) Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Specific Immunoglobulin G Subclass 4 (IgG4) Testing Growth Analysis And Strategic Analysis Framework

6. Specific Immunoglobulin G Subclass 4 (IgG4) Testing Market Segmentation

7. Specific Immunoglobulin G Subclass 4 (IgG4) Testing Market Regional And Country Analysis

8. Asia-Pacific Specific Immunoglobulin G Subclass 4 (IgG4) Testing Market

9. China Specific Immunoglobulin G Subclass 4 (IgG4) Testing Market

10. India Specific Immunoglobulin G Subclass 4 (IgG4) Testing Market

11. Japan Specific Immunoglobulin G Subclass 4 (IgG4) Testing Market

12. Australia Specific Immunoglobulin G Subclass 4 (IgG4) Testing Market

13. Indonesia Specific Immunoglobulin G Subclass 4 (IgG4) Testing Market

14. South Korea Specific Immunoglobulin G Subclass 4 (IgG4) Testing Market

15. Western Europe Specific Immunoglobulin G Subclass 4 (IgG4) Testing Market

16. UK Specific Immunoglobulin G Subclass 4 (IgG4) Testing Market

17. Germany Specific Immunoglobulin G Subclass 4 (IgG4) Testing Market

18. France Specific Immunoglobulin G Subclass 4 (IgG4) Testing Market

19. Italy Specific Immunoglobulin G Subclass 4 (IgG4) Testing Market

20. Spain Specific Immunoglobulin G Subclass 4 (IgG4) Testing Market

21. Eastern Europe Specific Immunoglobulin G Subclass 4 (IgG4) Testing Market

22. Russia Specific Immunoglobulin G Subclass 4 (IgG4) Testing Market

23. North America Specific Immunoglobulin G Subclass 4 (IgG4) Testing Market

24. USA Specific Immunoglobulin G Subclass 4 (IgG4) Testing Market

25. Canada Specific Immunoglobulin G Subclass 4 (IgG4) Testing Market

26. South America Specific Immunoglobulin G Subclass 4 (IgG4) Testing Market

27. Brazil Specific Immunoglobulin G Subclass 4 (IgG4) Testing Market

28. Middle East Specific Immunoglobulin G Subclass 4 (IgG4) Testing Market

29. Africa Specific Immunoglobulin G Subclass 4 (IgG4) Testing Market

30. Specific Immunoglobulin G Subclass 4 (IgG4) Testing Market Competitive Landscape And Company Profiles

31. Specific Immunoglobulin G Subclass 4 (IgG4) Testing Market Other Major And Innovative Companies

32. Global Specific Immunoglobulin G Subclass 4 (IgG4) Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Specific Immunoglobulin G Subclass 4 (IgG4) Testing Market

34. Recent Developments In The Specific Immunoglobulin G Subclass 4 (IgG4) Testing Market

35. Specific Immunoglobulin G Subclass 4 (IgG4) Testing Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기